Keywords
intraoperative navigation
lymphadenectomy
How to Cite
Abstract
In press
Radical gastrectomy with D2 lymphadenectomy remains the primary treatment method for gastric adenocarcinoma. However, lymph node dissection in gastric cancer surgery is sometimes performed incompletely and is not accompanied by additional imaging techniques. Consequently, comprehensive lymphadenectomy is challenging. It leads to reduced volume of dissected lymph node. This study assessed the safety of gastric tumor marking and the frequency of Sentinel Lymph Node (SLN) detection through fluorescent imaging for intraoperative navigation using IndoСyanine Green (ICG) in gastric cancer. We conducted single-arm prospective observational study. The study included patients who met the inclusion criteria, underwent diagnostic laparoscopy for gastric cancer staging and received 2 to 4 cycles of neoadjuvant chemotherapy following either the FLOT (Fluorouracil, Leucovorin, Oxaliplatin and docetaxel) or FOLFOX (FluOrouracil, Leucovorin, OXaliplatin) regimen. Radical gastrectomy or distal subtotal gastric resection was performed after the neoadjuvant phase. At least one SLN was detected in 23 out of 25 patients. Among these 23 patients, the mean number of fluorescently visualized lymph nodes was 5.8±4.2 per individual patient. Among the 23 patients with identified fluorescent lymph nodes, 20 (86.9%) had at least one metastatic fluorescent lymph node, suggesting a potential tendency for contrast accumulation in metastatic lymph nodes. IGC can be safely employed for intraoperative navigation and determining the extent of lymph node dissection in gastric cancer surgery. It is safe for patients and does not induce acute or long-term adverse reactions. The use of ICG does not prolong the duration of surgical intervention and enhances intraoperative navigation through simple and accessible visualization of SLN.
Keywords: sentinel lymphatic nodule, intraoperative navigation, lymphadenectomy.
References
Ke B, Liang H. Current status of lymph node dissection in gastric cancer. Chin J Cancer Res. 2021;33(2):193-202. DOI: 10.21147/j.issn.1000-9604.2021.02.07. PMID: 34158739.
Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20(2):167-92. DOI: 10.6004/jnccn.2022.0008. PMID: 35130500.
Kinami S, Saito H, Takamura H. Significance of Lymph Node Metastasis in the Treatment of Gastric Cancer and Current Challenges in Determining the Extent of Metastasis. Front Oncol. 2021;11:806162. DOI 10.3389/fonc.2021.806162. PMID: 35071010.
Goyal A. New Technologies for Sentinel Lymph Node Detection. Breast Care (Basel). 2018;13(5):349-53. DOI: 10.1159/000492436. PMID: 30498420.
Yoon BW, Lee WY. The oncologic safety and accuracy of indocyanine green fluorescent dye marking in securing the proximal resection margin during totally laparoscopic distal gastrectomy for gastric cancer: a retrospective comparative study. World J Surg Oncol. 2022;20(1):26. DOI: 10.1186/s12957-022-02494-5. PMID: 35090476.
AV DS, Lin H, Henderson ER, Samkoe KS, Pogue BW. Review of fluorescence guided surgery systems: identification of key performance capabilities beyond indocyanine green imaging. J Biomed Opt. 2016;21(8):80901. DOI: 10.1117/1.JBO.21.8.080901. PMID: 27533438.
Panaro F, Benedetti E, Pineton de Chambrun G, Habibeh H, Leon P, Bouyabrine H, et al. Indocyanine green fluorescence angiography during liver and pancreas transplantation: a tool to integrate perfusion statement's evaluation. Hepatobiliary Surg Nutr. 2018;7(3):161-6. DOI: 10.21037/hbsn.2017.07.02. PMID: 30046566.
Van Manen L, Handgraaf HJM, Diana M, Dijkstra J, Ishizawa T, Vahrmeijer AL, et al. A practical guide for the use of indocyanine green and methylene blue in fluorescence-guided abdominal surgery. J Surg Oncol. 2018;118(2):283-300. DOI: 10.1002/jso.25105. PMID: 29938401.
Maarek JM, Holschneider DP, Harimoto J, Yang J, Scremin OU, Rubinstein EH. Measurement of cardiac output with indocyanine green transcutaneous fluorescence dilution technique. Anesthesiology. 2004;100(6):1476-83. DOI: 10.1097/00000542-200406000-00020. PMID: 15166567.
Marano L, Carbone L, Poto GE, Restaino V, Piccioni SA, Verre L, et al. Extended Lymphadenectomy for Gastric Cancer in the Neoadjuvant Era: Current Status, Clinical Implications and Contentious Issues. Curr Oncol. 2023;30(1):875-96. DOI 10.3390/curroncol30010067. PMID: 36661716.
Lim ZY, Mohan S, Balasubramaniam S, Ahmed S, Siew CCH, Shelat VG. Indocyanine green dye and its application in gastrointestinal surgery: The future is bright green. World J Gastrointest Surg. 2023;15(9):1841-57. DOI 10.4240/wjgs.v15.i9.1841. PMID: 37901741.
Chen QY, Xie JW, Zhong Q, Wang JB, Lin JX, Lu J, et al. Safety and Efficacy of Indocyanine Green Tracer-Guided Lymph Node Dissection During Laparoscopic Radical Gastrectomy in Patients with Gastric Cancer: A Randomized Clinical Trial. JAMA Surg. 2020;155(4):300-11. DOI 10.1001/jamasurg.2019.6033. PMID: 32101269.
Li H, Xie X, Du F, Zhu X, Ren H, Ye C, et al. A narrative review of intraoperative use of indocyanine green fluorescence imaging in gastrointestinal cancer: situation and future directions. J Gastrointest Oncol. 2023;14(2):1095-13. DOI 10.21037/jgo-23-230. PMID: 37201097.
Al-Batran SE, Homann N, Pauligk C, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019;393(10184):1948-57. DOI:10.1016/S0140-6736(18)32557-1. PMID: 30982686.
Masuishi T, Kadowaki S, Kondo M, Komori A, Sugiyama K, Mitani S, et al. FOLFOX as First-line Therapy for Gastric Cancer with Severe Peritoneal Metastasis. Anticancer Res. 2017;37(12):7037-42. DOI: 10.21873/anticanres.12174. PMID: 29187492.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.